Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | ST316 |
Synonyms | |
Therapy Description |
ST316 is a peptide antagonist that disrupts the interaction between beta-catenin and its co-activator BCL9, resulting in decreased downstream signaling and potentially leading to enhanced T-cell activation and inhibition of tumor growth (Cancer Res (2023) 83 (8_Supplement): LB016). |